Accès ouvert
2026
article
OpenAlex
Festus Muigai Njuguna, Carole Jesang Kilach, Cyrus Njuguna, Erick Ayaye et autres
Background: Globally, approximately 515,000 infants with Sickle Cell Disease (SCD) are born every year. Approximately 80% of these cases occur in Sub‑Saharan Africa (SSA) annually, including 14,000 newborns in Kenya. In SSA, 50%–80% of children will die before the age of 5 …
Kenya, us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
C. J. Kilach, Cyrus Njuguna, Festus Muigai Njuguna, C. M. Wanjiku et autres
Hemophilic pseudotumors, a rare complication of bleeding disorders, are more common in settings with limited access to clotting factor concentrates. Subcutaneous emicizumab, a relatively novel therapy for hemophilia A, was investigated for its ability to stabilize an inoperable pseudotumor in a patient …
Kenya, us
(code pays fourni par la source)
Accès ouvert
2023
conference-abstract
OpenAlex
Christopher Wanjiku, Cyrus Njuguna, David Lazris, Julia Zhe Xu et autres
Introduction Sickle cell disease (SCD) is the most common hemoglobinopathies in the world. It is more prevalent in malaria endemic areas where most low-and-middle-income countries (LMIC) are found. Because of challenges in accessing care, persons with SCD (PWSCD) in these settings have …
us, Kenya
(code pays fourni par la source)
2021
conference-abstract
OpenAlex
Christopher Mwaniki Wanjiku, Festus Muigai Njuguna, Anne Greist, Erick Ayaye et autres
Abstract Introduction: Sickle cell disease (SCD) is the most common hemoglobinopathy in the world and it disproportionately affects population in tropical, resource-constrained regions where there is a high prevalence of malaria. Efforts to screen for SCD have been highly prioritized in these …
us, Kenya
(code pays fourni par la source)
2021
conference-abstract
OpenAlex
Carole Jesang Kilach, Christopher Mwaniki Wanjiku, Joseph Kipkoech Kirui, Racheal Korir et autres
Abstract Introduction: Persons with hemophilia (PWH) who develop need for surgery usually require a huge amount of clotting factor concentrate (CFC) infusion to manage their bleeding during the procedure and up to a few days or weeks afterwards until they achieve tissue …
Kenya, us
(code pays fourni par la source)
2018
conference-abstract
OpenAlex
Christopher Mwaniki Wanjiku, Festus Muigai Njuguna, Fredrick Chite Asirwa, Cyrus Njuguna et autres
Abstract Introduction and Objectives Sickle cell disease (SCD) is a neglected tropical disease disproportionally affecting malaria endemic regions of sub-Saharan Africa. Estimated to affect up to 3% of the population in some areas, 50-90% of children affected with SCD die before age …
Kenya, us
(code pays fourni par la source)